Topical phospho-sulindac (OXT-328) is effective in the treatment of non-melanoma skin cancer

Phospho-sulindac (P-S, OXT-328), a novel sulindac derivative, has shown superior anticancer efficacy and safety compared to sulindac. In this study, we investigated the efficacy of topical P-S hydrogel in the treatment of non-melanoma skin cancer in preclinical models. P-S is a potent inhibitor of A...

Descripción completa

Detalles Bibliográficos
Autores principales: CHENG, KA WING, MATTHEOLABAKIS, GEORGE, WONG, CHI C., OUYANG, NENGTAI, HUANG, LIQUN, CONSTANTINIDES, PANAYIOTIS P., RIGAS, BASIL
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2012
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583614/
https://www.ncbi.nlm.nih.gov/pubmed/22842609
http://dx.doi.org/10.3892/ijo.2012.1577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583614/
https://www.ncbi.nlm.nih.gov/pubmed/22842609
http://dx.doi.org/10.3892/ijo.2012.1577

Ejemplares similares